Funding Varies

Due: Applications Ongoing

Summary: The purpose of this funding opportunity announcement (FOA) is to fund clinical trials of products evaluating safety and/or efficacy in support of a new indication or change in labeling to address unmet needs in rare diseases or conditions. Additionally, through the funding of collaborative, efficient, and/or innovative clinical trials, FDA expects… Read More

$500,000

Due: 2022-07-22

Summary: The purpose of the funding opportunity is to expand and advance FDA's Office of Minority Health and Health Equity (OMHHE) work with stakeholders and partners for education, outreach, and public awareness activities on the use of and potential risks from skin lightening products (e.g., hydroquinone).Applicants will propose innovative and community-based… Read More

Funding Varies

Due: 2022-08-03

Summary: The U.S. Food and Drug Administration (FDA) seeks applications to develop, disseminate, implement, and evaluate an evidence-based Clinical Practice Guideline (CPG) for the safe tapering of benzodiazepines. Applicants must propose a comprehensive evidence-based plan that advances safe tapering of benzodiazepines. Read More

Funding Varies

Due: 2022-08-03

Summary: The U.S. Food and Drug Administration (FDA) seeks applications to develop, disseminate, implement, and evaluate an evidence-based Clinical Practice Guideline (CPG) for the management of postoperative pain in obstetric patients who have undergone surgeries, including but not limited to cesarean delivery, vaginal delivery, and appendectomy during pregnancy.… Read More

Funding Varies

Due: Applications Ongoing

Summary: This NOFO will provide support, depending on availability of FDA funding, for several Centers of Excellence in Regulatory Science and Innovation (CERSIs). The awarded institutions will advance the Agency's regulatory science goals through cutting-edge collaborative research with FDA and training in regulatory science, such as fellowships and scholars… Read More

Funding Varies

Due: 2023-05-03

Summary: The purpose of this funding opportunity announcement (FOA) is to support research to continue the development of drug development tools that have an accepted Letter of Intent (LOI) within a drug development tool qualification program within either CBER or CDER.The grants will be used to further the development of tools that, once qualified, will be… Read More

$500,000

Due: 2024-04-02

Summary: FDA announces the availability of fiscal year (FY) 2022 funds to support studies that identify the most common drivers for antimicrobial use in animal agriculture and identify potential alternatives to antimicrobials that may reduce the need for antimicrobial use. The funded studies are intended to 1) provide information about animal diseases that… Read More

Funding Varies

Due: Applications Ongoing

Summary: The BsUFA program requires substantial programmatic involvement to ensure the projects are applicable across more than one product or product class and the intended outcomes of these studies must be translatable to regulatory expectations. By using the cooperative agreement mechanism, the program will be able to have more interactions with the projects;… Read More

$1,800,000

Due: 2024-02-10

Summary: The purpose of this Funding Opportunity Announcement (FOA) is to solicit applications from institutions/ organizations for inclusion into FDA's Veterinary Laboratory Investigation and Response Network Cooperative Agreement Program for Veterinary Diagnostic laboratories. This cooperative agreement program is intended to build domestic laboratory… Read More

$1,600,000

Due: Applications Ongoing

Summary: The purpose of this funding opportunity announcement (FOA) is to support studies that advance medical product development through the characterization of the natural history of rare diseases/conditions with unmet needs. Through the support of efficient and innovative natural history studies, FDA expects to address critical knowledge gaps, to remove… Read More

Funding Varies

Due: Applications Ongoing

Summary: Data concepts (not just the information but the underlying definition of its meaning) between many different sources of RWD (EHRs, Claims, digital health technologies, etc.) as well as those used in clinical research and regulatory submission are almost always similar but not identical. This fact makes mapping and transforming data between RWD and… Read More

Funding Varies

Due: Applications Ongoing

Summary: The objective of this project is to develop a nasal PBPK model that includes at least one pathway for nose-to-brain drug delivery and links with a full body PBPK model that includes, at least, a brain compartment. It is expected that the model will rely on experimental data as much as possible, where experimental studies may need to be included in… Read More

Funding Varies

Due: Applications Ongoing

Summary: The objective of this work is to support the research to develop in vitro test methods for TDS that can correlate with and be predictive of TDS adhesion performance in vivo. The expected outcome of this research is that novel in vitro test methods will be developed which subject the TDS to biorelevant conditions that make it possible to establish in… Read More

Funding Varies

Due: 2024-02-13

Summary: The purpose of this funding opportunity announcement (FOA) is to support efficient and innovative natural history studies that advance medical product development in rare diseases/conditions with unmet needs. Through the support of natural history studies with high quality and interpretable data elements, FDA expects to address critical knowledge gaps,… Read More

$500,000

Due: 2024-02-02

Summary: This Notice of Funding Opportunity (NOFO) is issued by the Food and Drug Administration (FDA), Center for Veterinary Medicine (CVM), and solicits Research Project (R01) grant applications from institutions or organizations that propose to develop or support the development of designated new animal drugs intended for minor uses in major species or for… Read More

Funding Varies

Due: Applications Ongoing

Summary: The purpose of the NOFO is to expand and advance FDA's Office of Minority Health and Health Equity (OMHHE) work with stakeholders and partners for education, outreach, and public awareness activities on the dangers of skin lightening products containing hydroquinone and mercury.Applicants will propose innovative and community based strategies… Read More

Funding Varies

Due: Applications Ongoing

Summary: OMHHE’s Enhance Equity Initiative will support research projects that enhance EQUITY in clinical trials by supporting efforts to advance clinical trial diversity, EQUITABLE data efforts by increasing data available on diverse groups including, but not limited to, ethnicity, race, age, disability and geography, and EQUITY of voices by amplifying… Read More

$1,800,000

Due: Applications Ongoing

Summary: This project will continue a 10 year program that has sought to provide collaborative training, hands-on training and education for government, academic, and industry researchers. As such, the outcomes of the project are not limited to FDA (or interagency partners), but extend to both the research community (in order to better operate in high consequence… Read More

$1,000,000

Due: Applications Ongoing

Summary: ACTTION/PASI public-private partnership (PPP) is a multi-year, multi-phase initiative that is aligned with the FDA's Critical Path Initiative. This ppp has been designed to streamline the discovery and development process for new analgesic, anesthetic, addiction, and peripheral neuropathy medications. In addition, this PPP is established to address… Read More

$5,000,000

Due: Applications Ongoing

Summary: The purpose of this funding opportunity announcement (FOA) is to fund COVID research that will strengthen and advance research in minority health and healthy equity, increase understanding of health disparities, and provide future direction for research that will contribute to regulatory decision making.OMHHE is interested in research proposals that… Read More

Funding Varies

Due: Applications Ongoing

Summary: The proposed cooperative agreement is a renewal of the existing CAP supporting key stakeholders in retail food safety to coordinate and advance retail food protection in the United States. The intended outcome of this NOFO is to collaboratively advance retail food safety initiatives to reduce food-borne illness. This cooperative agreement is intended… Read More

$35,000,000

Due: 2023-03-01

Summary: The overall purpose of this funding is to advance efforts for a national integrated food safety system (IFSS) by supporting state and territory Produce Safety Programs to enhance produce safety and achieve high rates of compliance with the FDA’s Produce Safety Rule by way of regulatory programs focused on quality and national consistency; education… Read More

$4,500,000

Due: 2023-09-02

Summary: The purpose of this Funding Opportunity Announcement (FOA) is to support enhanced human and animal food safety by strengthening the capacity, collaboration, and integration of food-safety laboratories and networks, thereby facilitating an effective and coordinated response to future human and animal food safety issues. The current FOA solicits applications… Read More

$3,000,000

Due: Applications Ongoing

Summary: CBER seeks to advance the development of gene therapies for diseases affecting very small populations, potentially even single individuals, by enhancing innovations in the manufacture of Adeno-associated virus (AAV) vectors. Such innovations include the definition of critical quality attributes of AAV as vectors for gene therapy, development of advanced… Read More

$2,000,000

Due: Applications Ongoing

Summary: CBER seeks to support the application of novel technologies for advanced manufacturing of complex biologic products, and innovative analytical approaches to improve product manufacturing and quality through active research. One such technology is continuous manufacturing, defined as manufacturing using a continuous process, rather than a batch-process… Read More

$8,000,000

Due: Applications Ongoing

Summary: This research will advance pathogen reduction technologies by developing innovative technologies and by bridging the gaps between discoveries in academia or industry and ultimately implementation by blood establishments. Results of this comprehensive research will support integrated pathogen reduction technologies (PRT) for the blood safety. The overall… Read More

Funding Varies

Due: Applications Ongoing

Summary: This Notice of Funding Opportunity (NOFO) is issued by the Food and Drug Administration (FDA), Center for Veterinary Medicine (CVM), and solicits Research Project (R01) grant applications from institutions or organizations that propose to develop or support the development of designated new animal drugs intended for minor uses in major species or for… Read More

Funding Varies

Due: Applications Ongoing

Summary: For generic drug development, population pharmacokinetics (popPK) analysis is a critical part of the emerging technology of model-based bioequivalence (BE) analysis. PopPK models provide support for generalizing the conclusion of BE to groups that were not included in a BE study. The popPK model selection is essentially a multiple-objectives/variables… Read More

Funding Varies

Due: Applications Ongoing

Summary: The drug development tool programs at FDA are created to assist the applicants to successfully complete the qualification process, and to make the qualified tools available openly. Not only the program staff but also subject matter experts from FDA are involved to guide them to create most useful and widely acceptable tools through meetings and other… Read More

Funding Varies

Due: Applications Ongoing

Summary: In 2018, OPSA launched an effort to develop of a quantitative system-dynamic model of the opioid crisis to help FDA a) understanding the complexity of the interconnected mechanisms of the crisis, and b) assess potential impacts (intended and unintended) of possible policy actions to address the crisis. In Sept 2019, OPSA awarded a 1-year cooperative… Read More

Funding Varies

Due: Applications Ongoing

Summary: The overall objective of this funding opportunity is to develop an enhanced mechanistic PBPK model for generic dermatological drug products by accounting for the absorption and evaporation of vehicle/co-solvent simultaneously and implementing the effect of these two dynamic processes on the permeation of a drug molecule through skin. The developed… Read More

Funding Varies

Due: Applications Ongoing

Summary: The purpose of this funding opportunity is to systematically quantify the protein levels of potential metabolizing enzymes and transporters in rabbit eye and human eye tissue, human skin tissue, or human lung tissue using most advanced techniques available. Subsequently, the experimental data collected from this study will be implemented into existing… Read More

Funding Varies

Due: Applications Ongoing

Summary: Impulse oscillometry (IOS) is a technique used to assess lung function that does not require patient coordination, that uses sound waves that are introduced to the subject's lung airways. Research has suggested that in some cases, one or more IOS clinical endpoints may be more sensitive to differences in lung function than the spirometric measurement… Read More

Funding Varies

Due: Applications Ongoing

Summary: ACTTION public-private partnership (PPP) is a multi-year, multi-phase initiative that is aligned with the FDA's Critical Path Initiative. This ppp has been designed to streamline the discovery and development process for new analgesic, anesthetic, addiction, and peripheral neuropathy medications. The ppp is expected to develop innovative approaches… Read More

Funding Varies

Due: Applications Ongoing

Summary: Millions of children receive anesthetic and sedation drugs each year for surgical and non-surgical procedures. Over the past two decades, an expanding body of data from animal studies have demonstrated that exposure of the developing brain to anesthetic and sedation agents is associated with neurodegeneration and long-term, likely permanent, deficits… Read More

Funding Varies

Due: Applications Ongoing

Summary: Current US Food and Drug Administration product specific guidance (PSG) bioequivalence (BE) recommendations for orally inhaled drug products such as metered dose inhalers (MDIs) and dry powder inhalers (DPIs) typically use a weight-of-evidence approach that includes in vitro studies, an in vivo pharmacokinetics (PK) study, and either an in vivo pharmacodynamics… Read More

Funding Varies

Due: Applications Ongoing

Summary: FDA's CTP is seeking to develop a smoking machine adaptor for use with electronic nicotine delivery systems (ENDS), cigars, and heated tobacco products that will require significant collaboration and research efforts with outside organizations. The selected organization(s) will develop a single universal adaptor, or standardized family of adaptors,… Read More

Funding Varies

Due: Applications Ongoing

Summary: The purpose of this grant is to provide funding for NEST ( National Evaluation System for health Technology) in hiring personnel with expertise regarding RWE ( Real Word Evidence). Real-world evidence is the clinical evidence regarding the usage and potential benefits or risks of a medical product derived from analysis of RWD. RWE can be generated… Read More

Funding Varies

Due: Applications Ongoing

Summary: The purpose of this announcement is to continue to support the implementation of NEST through operations of the NEST CC toward sustainable operations to coincide with the stated purposes and goals listed in Section IV.H of the Medical Device User Fee Act Performance Goals and Procedures, Fiscal Years 2018 Through 2022 letter MDUFA IV Commitment Letter… Read More

Funding Varies

Due: Applications Ongoing

Summary: The intended outcome of this FOA is to collaboratively advance retail food initiatives to reduce foodborne illness. This cooperative agreement is intended to advance practices in retail food protection and identify opportunities for collaboration to reduce the occurrence of foodborne illness risk factors. Read More

Funding Varies

Due: Applications Ongoing

Summary: The purpose of this FOA is to assist State, Local, Tribal, and Territorial (SLTT) retail food regulatory programs with achieving conformance with the Voluntary National Retail Food Regulatory Program Standards (VNRFRPS), helping to fulfill training needs, tracking inspector standardization, and other projects to provide jurisdictions resources to reduce… Read More

Funding Varies

Due: Applications Ongoing

Summary: 1. Assist the FDA in meeting provisions of the FDA Food Safety Modernization Act;2. Support the efforts of Federal, State, and local government agencies to build an Integrated National Food Safety System;3. Establish systems for sharing, promotion, and collaboration of best practices, guidance documents, sampling plans, procedures, memorandums of understanding,… Read More

Funding Varies

Due: Applications Ongoing

Summary: To identify, adapt, and/or develop, data standards and/or applications of data standards to improve the timeline of pharmaceutical development, application submission, regulatory review, and/or post-martketing activities including safety surveillance. Read More

Funding Varies

Due: Applications Ongoing

Summary: PBPK models are an effective tool to integrate the product characteristics and the physiology of the individual subject along with its variability within a population providing a means to simulate drug absorption and its subsequent disposition in the system without conducting in vivo pharmacokinetic studies. They have shown promise in supporting generic… Read More

Funding Varies

Due: Applications Ongoing

Summary: PBPK modeling and simulation tools have been extremely useful tools in the drug development process, in the interaction with regulatory agencies, and in decision making in the clinical setting. The objective of this NOFO is to promote further enhancements to improve the predictive power of these modeling and simulation tools and to expand their capabilities… Read More

Funding Varies

Due: Applications Ongoing

Summary: The purpose of the research is to develop methods for evaluating the impact of small design differences in the user interface of generic drug-device combination products when compared to the user interface of the reference listed drug (RLD). The results obtained from this research will be used to gain a better understanding of the factors related to… Read More

Funding Varies

Due: Applications Ongoing

Summary: The Food and Drug Administration (FDA) Office of the Chief Scientist (OCS) and FDA Center for Drug Evaluation and Research (CDER), Office of Medical Policy (OMP) will announce it's intent to accept and consider an application for the award of a grant to protect and promote the health of the American public by creating new, applied scientific knowledge,… Read More

Funding Varies

Due: Applications Ongoing

Summary: The purpose of this funding opportunity is to incorporate social outcomes (quality of life, untreated pain, etc.) and cost-effectiveness into FDA's existing model and policy analysis tool. Work resulting from this funding opportunity should provide more holistic insight into the opioid crisis and enhance decision-makers' ability to propose… Read More

Funding Varies

Due: Applications Ongoing

Summary: To support research projects that examine real-world data (RWD), real-world evidence (RWE), and related issues such as data analytics, the use of digital health tools, and innovative trial designs utilizing healthcare settings Read More

Funding Varies

Due: Applications Ongoing

Summary: The Substance Use-Disorder Prevention that Promotes Opioid Recovery and Treatment for Patients and Communities Act (known as the SUPPORT Act) was signed into law in October 2018. Section 3002 of the SUPPORT Act requires the Commissioner of Food and Drugs to develop evidence-based opioid analgesic prescribing guidelines for indication-specific treatment… Read More

Funding Varies

Due: Applications Ongoing

Summary: CBER, FDA seeks to support the development of innovative pathogen reduction technologies for whole blood and blood components to prevent transfusion-transmitted infectious diseases. Read More

Funding Varies

Due: Applications Ongoing

Summary: The Food and Drug Administration's (FDA), Office of Regulatory Affairs (ORA), Office of Training, Education, and Development (OTED) is announcing this Funding Opportunity Announcement (FOA) for a Cooperative Agreement. The goals of this Cooperative Agreement are to continue the development of the Integrated Food Safety System (IFSS) National Curriculum… Read More

Funding Varies

Due: 2022-10-11

Summary: The FDA recognizes the value of supporting high-quality conferences and scientific meetings relevant to its mission and to the public health. A conference or scientific meeting is defined as a symposium, seminar, workshop, or any formal meeting, whether conducted face-to-face or virtually to exchange information and explore a defined subject, issue,… Read More

$4,800,000

Due: 2022-07-28

Summary: The FY22 ALSRP Therapeutic Development Award (TDA) supports research ranging from validation of therapeutic leads through U.S. Food and Drug Administration (FDA) Investigational New Drug (IND)-enabling studies. The proposed studies are expected to be empirical in nature and product-driven. Applicants with limited ALS experience are strongly encouraged… Read More

Funding Varies

Due: 2023-04-05

Summary: This Funding Opportunity Announcement (FOA), issued by the National Institutes of Health (NIH), the Centers for Disease Control and Prevention (CDC), and the Food and Drug Administration (FDA), invites eligible United States small businesses to submit Small Business Innovation Research (SBIR) grant applications. United States small businesses that… Read More

$1,000,000

Due: 2023-03-08

Summary: The purpose of this Funding Opportunity Announcement (FOA) is to invite R21 applications to stimulate exploratory research relevant to the mission of the Food and Drug Administration (FDA) - Center for Tobacco Products (CTP) using existing (publicly available) biospecimens currently stored in repositories in the United States. This will include, but… Read More

$750,000

Due: Applications Ongoing

Summary: The National Science Foundation (NSF), through the Directoratefor Engineering, the Directorate of Computer and Information Science and Engineering Division of Computer and Network Systems, and the Directorate for Mathematical and Physical Sciences Division of Materials Research, along with the U.S. Food and Drug Administration (FDA), through its Center… Read More

Funding Varies

Due: 2023-02-14

Summary: The purpose of this Funding Opportunity Announcement (FOA) is to invite R01 applications to support biomedical and behavioral research that will provide scientific data to inform regulation of tobacco products to protect public health. Research Projects must address the research priorities related to the regulatory authority of the Food and Drug Administration… Read More

Funding Varies

Due: 2022-07-14

Summary: The purpose of this funding opportunity announcement (FOA) is to solicit applications for a Center for Coordination of Analysis, Science, Enhancement, and Logistics (CASEL) in Tobacco Regulatory Science. The overall objective of CASEL is scientific coordination and logistics and operations management of research projects and programs that can inform… Read More

Funding Varies

Due: 2022-07-14

Summary: The purpose of this Funding Opportunity Announcement (FOA) is to invite applications for Tobacco Centers of Regulatory Science (TCORS) to support biomedical and behavioral research that will provide scientific data to inform regulation of tobacco products to protect public health. Research Projects must address the Research Objectives related to the… Read More

$1,000,000

Due: 2023-03-08

Summary: The purpose of this Funding Opportunity Announcement (FOA) is to invite R21 applications proposing the innovative analysis of existing (publicly available) nationally representative U.S. cross-sectional and longitudinal data, to investigate novel scientific ideas and/or to generate new models, systems, tools, methods, or technologies that have the… Read More

Funding Varies

Due: 2025-01-07

Summary: Reissue of PAR-18-942. The purpose of this funding opportunity announcement (FOA) is to encourage applications seeking to develop the next generation of brain stimulation devices for treating mental health disorders. Applications are sought that will either 1) develop novel brain stimulation devices or 2) significantly enhance, by means of hardware/software… Read More

Funding Varies

Due: 2025-01-07

Summary: Reissue of PAR-18-941. The purpose of this funding opportunity announcement (FOA) is to encourage applications seeking to develop the next generation of brain stimulation devices for treating mental health disorders. Applications are sought that will either 1) develop novel brain stimulation devices or 2) significantly enhance, by means of hardware/software… Read More

Funding Varies

Due: 2022-07-19

Summary: This funding opportunity announcement (FOA) is part of a suite of FOAs of the NIH Common Fund Somatic Cell Genome Editing (SCGE) Phase II Program. The goal of this U19 FOA is to support team-based research Projects to accelerate further optimization and development of genome editing-based therapeutic leads towards IND-enabling studies and an IND (Investigational… Read More

$4,000,000

Due: 2024-02-20

Summary: The purpose of this Funding Opportunity Announcement (FOA) is to encourage applications from Small Business Concerns (SBCs) to pursue translational activities and small clinical studies to advance the development of therapeutic and diagnostic devices for disorders that affect the nervous or neuromuscular systems. The translational device activities,… Read More

Funding Varies

Due: 2023-04-05

Summary: The purpose of this Funding Opportunity Announcement (FOA) is to encourage applications from small business concerns (SBCs) to the newly re-authorized Commercialization Readiness Pilot (CRP) program. The FOA aims to facilitate the transition of previously funded SBIR and STTR Phase II and Phase IIB projects to the commercialization stage by providing… Read More

Funding Varies

Due: 2022-07-16

Summary: This Funding Opportunity Announcement (FOA) encourages Exploratory/Developmental Phase II (R33) grant applications to facilitate early-stage T1 translation (bench-to-bedside) of discoveries from basic and applied research in aging into novel therapeutics for the prevention and treatment of clinical conditions related to aging or multiple chronic conditions… Read More

Funding Varies

Due: 2022-07-16

Summary: This Funding Opportunity Announcement (FOA) encourages Exploratory/Developmental Phased Innovation (R21/R33) grant applications to facilitate early-stage T1 translation (bench-to-bedside) of discoveries from basic and applied research in aging into novel therapeutics for the prevention and treatment of clinical conditions related to aging and/or multiple… Read More

$1,600,000

Due: 2022-11-09

Summary: The FY22 VRP TRA is intended to support translational research that moves promising discoveries into clinical applications that will advance the prevention, diagnosis, mitigation, and/or treatment of eye injury or visual dysfunction associated with military exposure. Successful applications to the FY22 VRP TRA should establish a clear path to transforming… Read More

Funding Varies

Due: Applications Ongoing

Summary: PurposeThe COVID-19 Coverage Assistance Fund will provide claims reimbursement at the national Medicare rate for eligible healthcare providers administering authorized COVID-19 vaccines to underinsured individuals.To participate, providers must attest to the following at registration: Have submitted a vaccine administration claim to the patient's healthcare… Read More

Funding Varies

Due: 2024-12-04

Summary: This Funding Opportunity Announcement (FOA) supports Small Business Technology Transfer (STTR) applications from small business concerns (SBCs) that propose the development of therapeutic agents for the treatment of alcohol use disorder (AUD) and/or alcohol associated organ damage (AAOD). As a starting point, eligible applicants must identify a therapeutic… Read More

Funding Varies

Due: 2024-12-04

Summary: This Funding Opportunity Announcement (FOA) supports Small Business Innovation Research (SBIR) applications from small business concerns (SBCs) that propose the development of therapeutic agents for the treatment of alcohol use disorder (AUD) and/or alcohol associated organ damage (AAOD). As a starting point, eligible applicants must identify a therapeutic… Read More

$2,240,000

Due: 2022-09-23

Summary: The FY22 BMFRP IIRA will offer two funding levels with different intent:Funding Level 1 (FL1): To support studies that further develop ideas, expand upon key discoveries, and have the potential to make significant advances in research, patient care, and/or quality of life in the FY22 BMFRP IIRA Focus Areas. IIRA applications may involve basic, translational,… Read More

$10,000,000

Due: 2022-07-29

Summary: The Rural Communities Opioid Response Program (RCORP) is a multi-year HRSA initiative aimed at reducing the morbidity and mortality of substance use disorder (SUD), including opioid use disorder (OUD), in rural communities. This notice announces the opportunity to apply for funding under the RCORP-Medication Assisted Treatment (MAT) Access Program.… Read More

$3,800,000

Due: 2022-07-27

Summary: The FY22 LCRP Clinical Translational Research Partnership Award mechanism supports partnerships between clinicians and research scientists that will accelerate the movement of promising ideas in lung cancer into clinical applications. This award supports the development of translational research collaborations between two independent, faculty-level… Read More

$54,000,000

Due: 2022-08-12

Summary: The FY22 PRMRP Focused Program Award (FPA) is intended to optimize research and accelerate solutions to a critical question related to one of the congressionally directed FY22 PRMRP Topic Areas and one of the FY22 PRMRP Strategic Goals through a synergistic, multidisciplinary research program.Key aspects of this award include:Overarching Challenge:… Read More

$7,200,000

Due: 2022-11-02

Summary: The intent of the Breakthrough Award is to support promising research that has high potential to lead to or make breakthroughs in breast cancer. The critical components of this award mechanism are: Impact: Research supported by the Breakthrough Award will have the potential for a major impact and accelerate progress toward ending breast cancer. The… Read More

$15,500,000

Due: 2022-11-02

Summary: The intent of the Breakthrough Award is to support promising research that has high potential to lead to or make breakthroughs in breast cancer. The critical components of this award mechanism are: Impact: Research supported by the Breakthrough Award will have the potential for a major impact and accelerate progress toward ending breast cancer. The… Read More

$8,000,000

Due: 2022-10-20

Summary: The KCRP Clinical Trial Award supports the rapid implementation of early-phase clinical trials (phase 0, phase 1, phase 1/2) with the potential to have a significant impact on the treatment or management of kidney cancer. Clinical trials may be designed to evaluate promising new products, pharmacologic agents (drugs or biologics), devices, surgical… Read More

Funding Varies

Due: 2022-08-01

Summary: ****AMMENDMENT 0001**** Section I paragraph A.2 is hereby revised to add the following: In accordance with 10 U.S.C. § 2371b(f) the Government may award a follow-on production contract or Other Transaction (OT) for any OT awarded under this BAA if: (1) that participant in the OT or a recognized successor in interest to the OT successfully completed… Read More

$4,420,000

Due: 2022-10-11

Summary: The MBRP CTRA is intended to support the rapid implementation of clinical research (including clinical trials) with the potential to significantly impact burn care by applying promising and well-founded research findings to the care of the burn-injured patient, particularly at the point-of-injury, or during the early, acute phase of burn injury. Impact:… Read More

$8,710,000

Due: 2022-09-14

Summary: The CRRP seeks to enhance medical capabilities and Force readiness at the point of greatest need in order to save the most lives in trauma care scenarios, which may be complicated by combat operations, limited resources, austere conditions, and/or mass casualty events. The intent of the FY22 CRRP RDTRA is to support research that will accelerate the… Read More

$9,600,000

Due: 2022-07-28

Summary: The FY22 ALSRP Pilot Clinical Trial Award supports the rapid implementation of clinical trials with the potential to have a significant impact on the treatment or management of ALS. Projects may range from phase 1 to small-scale phase 2 trials and should aim to de-risk and inform the design of more advanced trials by investigating safety, feasibility,… Read More

$6,000,000

Due: 2022-09-13

Summary: Orthopaedic injuries have a profound impact on military readiness and return to work/activity/duty. In the military, extremity battle wounds comprise approximately 50% of injuries reported in the Joint Theatre Trauma Registry. Additionally, orthopaedic injuries and conditions that occur outside of combat (e.g., during training, leisure activities,… Read More

$16,000,000

Due: 2022-09-13

Summary: Orthopaedic injuries have a profound impact on military readiness and return to work/activity/duty. In the military, extremity battle wounds comprise approximately 50% of injuries reported in the Joint Theatre Trauma Registry. Additionally, orthopaedic injuries and conditions that occur outside of combat (e.g., during training, leisure activities,… Read More